{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:45:57Z","timestamp":1787003157453,"version":"build-2736575974"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62072376"],"award-info":[{"award-number":["62072376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1C1C1010753"],"award-info":[{"award-number":["2021R1C1C1010753"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-024-00782-3","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T08:03:00Z","timestamp":1724832180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Exploring causal effects of sarcopenia on risk and progression of Parkinson disease by Mendelian randomization"],"prefix":"10.1038","volume":"10","author":[{"given":"Tao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaquan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Eun","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3857-7927","authenticated-orcid":false,"given":"Jiajie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"782_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"782_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 15, 1257\u20131272 (2016).","journal-title":"Lancet Neurol."},{"key":"782_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/mds.1090","volume":"16","author":"JE Ahlskog","year":"2001","unstructured":"Ahlskog, J. E. & Muenter, M. D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov. Disord. 16, 448\u2013458 (2001).","journal-title":"Mov. Disord."},{"key":"782_CR4","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1093\/brain\/123.11.2297","volume":"123","author":"A Schrag","year":"2000","unstructured":"Schrag, A. & Quinn, N. Dyskinesias and motor fluctuations in Parkinson\u2019s disease. A community-based study. Brain 123, 2297\u20132305 (2000).","journal-title":"Brain"},{"key":"782_CR5","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft, A. J. & Sayer, A. A. Sarcopenia. Lancet 393, 2636\u20132646 (2019).","journal-title":"Lancet"},{"key":"782_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155533","volume":"144","author":"S Yuan","year":"2023","unstructured":"Yuan, S. & Larsson, S. C. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism 144, 155533 (2023).","journal-title":"Metabolism"},{"key":"782_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.gerinurse.2022.11.006","volume":"49","author":"A Ponsoni","year":"2023","unstructured":"Ponsoni, A., Sardeli, A. V., Costa, F. P. & Mourao, L. F. Prevalence of sarcopenia in Parkinson\u2019s disease: a systematic review and meta-analysis. Geriatr. Nurs. 49, 44\u201349 (2023).","journal-title":"Geriatr. Nurs."},{"key":"782_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith, G. D. & Ebrahim, S. Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol. 32, 1\u201322 (2003).","journal-title":"Int. J. Epidemiol."},{"key":"782_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor, D. A., Harbord, R. M., Sterne, J. A., Timpson, N. & Davey Smith, G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat. Med. 27, 1133\u20131163 (2008).","journal-title":"Stat. Med."},{"key":"782_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.971913","volume":"9","author":"Z-H Zhao","year":"2022","unstructured":"Zhao, Z.-H., Zou, J., Huang, X., Fan, Y.-C. & Wang, K. Assessing causal relationships between sarcopenia and nonalcoholic fatty liver disease: a bidirectional Mendelian randomization study. Front. Nutr. 9, 971913 (2022).","journal-title":"Front. Nutr."},{"key":"782_CR11","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.18632\/aging.102815","volume":"12","author":"H-M Liu","year":"2020","unstructured":"Liu, H.-M. et al. Sarcopenia-related traits and coronary artery disease: a bi-directional Mendelian randomization study. Aging 12, 3340 (2020).","journal-title":"Aging"},{"key":"782_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1109800","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. A bi-directional Mendelian randomization study of sarcopenia-related traits and type 2 diabetes mellitus. Front. Endocrinol. 14, 1109800 (2023).","journal-title":"Front. Endocrinol."},{"key":"782_CR13","doi-asserted-by":"publisher","first-page":"e35071","DOI":"10.1097\/MD.0000000000035071","volume":"102","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Yang, M. & Li, M. Causality between sarcopenia-related traits and major depressive disorder: A bi-directional, two-sample Mendelian randomized study. Medicine 102, e35071 (2023).","journal-title":"Medicine"},{"key":"782_CR14","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1002\/mds.27873","volume":"34","author":"AJ Noyce","year":"2019","unstructured":"Noyce, A. J. et al. The Parkinson\u2019s disease Mendelian randomization research portal. Mov. Disord. 34, 1864\u20131872 (2019).","journal-title":"Mov. Disord."},{"key":"782_CR15","doi-asserted-by":"crossref","unstructured":"She, Y., He, Y., Wu, J. & Liu N. Association between the Sarcopenia-related traits and Parkinson\u2019s disease: a bidirectional two-sample Mendelian randomization study. Arch. Gerontol. Geriatr. 122, 105374 (2024).","DOI":"10.1016\/j.archger.2024.105374"},{"key":"782_CR16","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1073\/pnas.1401819111","volume":"111","author":"M Heiman","year":"2014","unstructured":"Heiman, M. et al. Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia. Proc. Natl. Acad. Sci. USA 111, 4578\u20134583 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"782_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1460-9568.2008.06387.x","volume":"28","author":"M Giorgi","year":"2008","unstructured":"Giorgi, M. et al. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms. Eur. J. Neurosci. 28, 941\u2013950 (2008).","journal-title":"Eur. J. Neurosci."},{"key":"782_CR18","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/mds.23245","volume":"25","author":"P Belujon","year":"2010","unstructured":"Belujon, P., Lodge, D. J. & Grace, A. A. Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment. Mov. Disord. 25, 1568\u20131576 (2010).","journal-title":"Mov. Disord."},{"key":"782_CR19","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1093\/brain\/awr158","volume":"134","author":"YZ Huang","year":"2011","unstructured":"Huang, Y. Z., Rothwell, J. C., Lu, C. S., Chuang, W. L. & Chen, R. S. Abnormal bidirectional plasticity-like effects in Parkinson\u2019s disease. Brain 134, 2312\u20132320 (2011).","journal-title":"Brain"},{"key":"782_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.nbd.2007.10.001","volume":"29","author":"B Picconi","year":"2008","unstructured":"Picconi, B. et al. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. Neurobiol. Dis. 29, 327\u2013335 (2008).","journal-title":"Neurobiol. Dis."},{"key":"782_CR21","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/mds.27783","volume":"34","author":"MJ Kelly","year":"2019","unstructured":"Kelly, M. J. et al. Predictors of motor complications in early Parkinson\u2019s disease: a prospective cohort study. Mov. Disord. 34, 1174\u20131183 (2019).","journal-title":"Mov. Disord."},{"key":"782_CR22","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00702-018-1900-6","volume":"125","author":"TN Tran","year":"2018","unstructured":"Tran, T. N., Vo, T. N. N., Frei, K. & Truong, D. D. Levodopa-induced dyskinesia: clinical features, incidence, and risk factors. J. Neural Transm. 125, 1109\u20131117 (2018).","journal-title":"J. Neural Transm."},{"key":"782_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10072-019-04073-1","volume":"41","author":"FF Ozer","year":"2020","unstructured":"Ozer, F. F., Akin, S., Gultekin, M. & Zararsiz, G. E. Sarcopenia, dynapenia, and body composition in Parkinson\u2019s disease: are they good predictors of disability?: a case-control study. Neurol. Sci. 41, 313\u2013320 (2020).","journal-title":"Neurol. Sci."},{"key":"782_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000492572","volume":"65","author":"M Peball","year":"2019","unstructured":"Peball, M. et al. Prevalence and associated factors of sarcopenia and frailty in Parkinson\u2019s disease: a cross-sectional study. Gerontology 65, 216\u2013228 (2019).","journal-title":"Gerontology"},{"key":"782_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.parkreldis.2018.06.020","volume":"56","author":"AH Tan","year":"2018","unstructured":"Tan, A. H. et al. Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 56, 58\u201364 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"782_CR26","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1093\/gerona\/glab082","volume":"76","author":"SJ Chung","year":"2021","unstructured":"Chung, S. J. et al. Temporalis muscle thickness as an indicator of sarcopenia is associated with long-term motor outcomes in Parkinson\u2019s disease. J. Gerontol. A Biol. Sci. Med. Sci. 76, 2242\u20132248 (2021).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"782_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jamda.2018.07.011","volume":"20","author":"RP McGrath","year":"2019","unstructured":"McGrath, R. P. Understanding the feasibility and validity of muscle strength measurements in aging adults. J. Am. Med. Dir. Assoc. 20, 99\u2013100 (2019).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"782_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.nbd.2014.08.002","volume":"71","author":"I Prescott","year":"2014","unstructured":"Prescott, I. et al. Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia. Neurobiol. Dis. 71, 24\u201333 (2014).","journal-title":"Neurobiol. Dis."},{"key":"782_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.biopsych.2014.04.002","volume":"77","author":"M Cerovic","year":"2015","unstructured":"Cerovic, M. et al. Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia. Biol. Psychiatry 77, 106\u2013115 (2015).","journal-title":"Biol. Psychiatry"},{"key":"782_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/brain\/awq342","volume":"134","author":"B Picconi","year":"2011","unstructured":"Picconi, B. et al. Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. Brain 134, 375\u2013387 (2011).","journal-title":"Brain"},{"key":"782_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1519\/00139143-200831010-00002","volume":"31","author":"RW Bohannon","year":"2008","unstructured":"Bohannon, R. W. Hand-grip dynamometry predicts future outcomes in aging adults. J. Geriatr. Phys. Ther. 31, 3\u201310 (2008).","journal-title":"J. Geriatr. Phys. Ther."},{"key":"782_CR32","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.27372","volume":"33","author":"SH Fox","year":"2018","unstructured":"Fox, S. H. et al. International Parkinson and movement disorder society evidence\u2010based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease. Mov. Disord. 33, 1248\u20131266 (2018).","journal-title":"Mov. Disord."},{"key":"782_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.14802\/jmd.18005","volume":"11","author":"A Kim","year":"2018","unstructured":"Kim, A. et al. Amantadine and the risk of dyskinesia in patients with early Parkinson\u2019s disease: an open-label, pragmatic trial. J. Mov. Disord. 11, 65 (2018).","journal-title":"J. Mov. Disord."},{"key":"782_CR34","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/01.wnl.0000310812.43352.66","volume":"71","author":"R Katzenschlager","year":"2008","unstructured":"Katzenschlager, R. et al. Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD. Neurology 71, 474\u2013480 (2008).","journal-title":"Neurology"},{"key":"782_CR35","doi-asserted-by":"crossref","unstructured":"Daniels, J. et al. Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson\u2019s disease (PD MED): a large, open-label, pragmatic randomised trial. Lancet 384, 1196\u20131205 (2014).","DOI":"10.1016\/S0140-6736(14)60683-8"},{"key":"782_CR36","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.parkreldis.2014.09.016","volume":"20","author":"N Giladi","year":"2014","unstructured":"Giladi, N., Ghys, L., Surmann, E., Boroojerdi, B. & Jankovic, J. Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson\u2019s disease. Parkinsonism Relat. Disord. 20, 1345\u20131351 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"782_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/nutrit\/nuaa011","volume":"79","author":"E Gielen","year":"2021","unstructured":"Gielen, E. et al. Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses. Nutr. Rev. 79, 121\u2013147 (2021).","journal-title":"Nutr. Rev."},{"key":"782_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.arr.2010.03.004","volume":"9","author":"MD Peterson","year":"2010","unstructured":"Peterson, M. D., Rhea, M. R., Sen, A. & Gordon, P. M. Resistance exercise for muscular strength in older adults: a meta-analysis. Ageing Res. Rev. 9, 226\u2013237 (2010).","journal-title":"Ageing Res. Rev."},{"key":"782_CR39","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","volume":"14","author":"J Bauer","year":"2013","unstructured":"Bauer, J. et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J. Am. Med. Dir. Assoc. 14, 542\u2013559 (2013).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"782_CR40","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jamda.2015.05.021","volume":"16","author":"JM Bauer","year":"2015","unstructured":"Bauer, J. M. et al. Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. J. Am. Med. Dir. Assoc. 16, 740\u2013747 (2015).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"782_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58416-w","volume":"14","author":"C-f Lu","year":"2024","unstructured":"Lu, C.-f. et al. The bidirectional associations between sarcopenia-related traits and cognitive performance. Sci. Rep. 14, 7591 (2024).","journal-title":"Sci. Rep."},{"key":"782_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13923","volume":"22","author":"C Ye","year":"2023","unstructured":"Ye, C. et al. Causal associations of sarcopenia\u2010related traits with cardiometabolic disease and Alzheimer\u2019s disease and the mediating role of insulin resistance: a Mendelian randomization study. Aging Cell 22, e13923 (2023).","journal-title":"Aging Cell"},{"key":"782_CR43","doi-asserted-by":"publisher","first-page":"112636","DOI":"10.1016\/j.biopha.2022.112636","volume":"147","author":"D Jo","year":"2022","unstructured":"Jo, D., Yoon, G., Kim, O. Y. & Song, J. A new paradigm in sarcopenia: cognitive impairment caused by imbalanced myokine secretion and vascular dysfunction. Biomed. Pharmacother. 147, 112636 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"782_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/aje\/kwy204","volume":"188","author":"JA Labrecque","year":"2019","unstructured":"Labrecque, J. A. & Swanson, S. A. Interpretation and potential biases of Mendelian randomization estimates with time-varying exposures. Am. J. Epidemiol. 188, 231\u2013238 (2019).","journal-title":"Am. J. Epidemiol."},{"key":"782_CR45","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"K Marek","year":"2011","unstructured":"Marek, K. et al. The Parkinson progression marker initiative (PPMI). Prog. Neurobiol. 95, 629\u2013635 (2011).","journal-title":"Prog. Neurobiol."},{"key":"782_CR46","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 7, e34408 (2018).","journal-title":"eLife"},{"key":"782_CR47","unstructured":"Mitchell, R. et al. MRC IEU UK Biobank GWAS Pipeline Version 2 (University of Bristol, 2019)."},{"key":"782_CR48","unstructured":"UK Biobank. Grip strength measurement Version 1.0. https:\/\/biobank.ndph.ox.ac.uk\/showcase\/ukb\/docs\/Gripstrength.pdf (2021)."},{"key":"782_CR49","doi-asserted-by":"crossref","unstructured":"Pei, Y. et al. The genetic architecture of appendicular lean mass characterized by association analysis in the UK Biobank study. Commun. Biol. 3, 608 (2020).","DOI":"10.1038\/s42003-020-01334-0"},{"key":"782_CR50","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518 (2023).","journal-title":"Nature"},{"key":"782_CR51","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/mds.27845","volume":"34","author":"H Iwaki","year":"2019","unstructured":"Iwaki, H. et al. Genomewide association study of Parkinson\u2019s disease clinical biomarkers in 12 longitudinal patients\u2019 cohorts. Mov. Disord. 34, 1839\u20131850 (2019).","journal-title":"Mov. Disord."},{"key":"782_CR52","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658\u2013665 (2013).","journal-title":"Genet. Epidemiol."},{"key":"782_CR53","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512\u2013525 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"782_CR54","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304\u2013314 (2016).","journal-title":"Genet. Epidemiol."},{"key":"782_CR55","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/ije\/dyy101","volume":"47","author":"J Bowden","year":"2018","unstructured":"Bowden, J. et al. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the radial plot and radial regression. Int. J. Epidemiol. 47, 1264\u20131278 (2018).","journal-title":"Int. J. Epidemiol."},{"key":"782_CR56","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess, S. et al. Guidelines for performing Mendelian randomization investigations. Wellcome Open Res. 4, 186 (2019).","journal-title":"Wellcome Open Res"},{"key":"782_CR57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","volume":"88","author":"J Yang","year":"2011","unstructured":"Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76\u201382 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"782_CR58","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"782_CR59","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284\u20131287 (2016).","journal-title":"Nat. Genet."},{"key":"782_CR60","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/ng.3643","volume":"48","author":"S McCarthy","year":"2016","unstructured":"McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279\u20131283 (2016).","journal-title":"Nat. Genet."},{"key":"782_CR61","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3679","volume":"48","author":"PR Loh","year":"2016","unstructured":"Loh, P. R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet. 48, 1443\u20131448 (2016).","journal-title":"Nat. Genet."},{"key":"782_CR62","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","volume":"47","author":"U Raudvere","year":"2019","unstructured":"Raudvere, U. et al. g: Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47, W191\u2013W198 (2019).","journal-title":"Nucleic Acids Res."},{"key":"782_CR63","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gky962","volume":"47","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M., Sato, Y., Furumichi, M., Morishima, K. & Tanabe, M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 47, D590\u2013D595 (2019).","journal-title":"Nucleic Acids Res."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00782-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00782-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00782-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T09:03:49Z","timestamp":1724835829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00782-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1038\/s41531-024-00782-3","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"9 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"164"}}